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The isolation, purification and identification of antibac-
terial compounds from Euclea crispa subsp. crispa
reported here, is a continuation of earlier work. Most of
the antimicrobial activity was located in an ethyl acetate
fraction obtained by means of liquid–liquid extraction.
Subsequent purification of this fraction, by means of
multiple preparative thin layer chromatography using
different solvent systems, revealed the presence of
essential oils, bitter principles and saponins, all ter-
penoid derivatives, as well as alkaloids and phenolic
compounds. A terpenoid that tested positive for bitter
principles and for saponins, and possessed a steroid-
like structure, was isolated and purified from the ethyl
acetate fraction. This compound was active against the
Gram-negative Moraxella catarrhalis. Also isolated from
the ethyl acetate fraction, and showing antimicrobial
activity as individual compounds, were five flavonoids
identified as catechin, epicatechin, gallocatechin,
hyperoside and quercitrin. Of these epicatechin and
hyperoside were most active in inhibiting the growth of
M. catarrhalis (–), Streptococcus pneumoniae (+) and
Haemophilus influenza (–). The isolated flavonoids
seemed, in general, to have less activity than the entire
ethyl acetate fraction, suggesting that these com-
pounds function in synergy.
The spread of AIDS and treatment of immune related dis-
eases with immunosuppressive drugs indicates that the
occurrence of weaknesses in the immune system of humans
is increasingly prevalent. Associated with this is the increas-
ing predisposition of immuno-compromised patients to bac-
terial and fungal attack. The infections commonly observed
in such hosts include candidiasis, caused by Candida albi-
cans and other species, cryptococcosis, caused by
Cryptococcus neoformans, and also aspergillosis, caused by
Aspergillus flavus, A. fumigatus and A. niger (Hostettmann
and Marston 1994). Other diseases frequently observed are
respiratory in nature and are due to streptococcal, staphylo-
coccal and Haemophilus pneumoniae infections, as well as
systemic infections caused by Streptococcus pneumoniae,
S. pyogenes and Neisseria meningitidis, among other bacte-
ria (Brock and Madigan 1991). Although the search for
antimicrobial agents is in progress in many phytochemical
laboratories, no plant derived compound has yet been found
which can compete with clinically used antibiotics
(Hamburger and Hostettmann 1991). This does not mean
that such natural compounds do not exist.
The plant kingdom can be regarded as a largely untapped
store of phytochemicals (Aquino et al. 1995) as evidenced
by some interesting facts. Roughly 40 million square kilome-
ters of the earth’s surface are covered by forests, half of
which are tropical forests and one third rain forests
(Farnsworth and Bingel 1977, Rasoanaivo and
Ratsamimanga 1993). Of all the species of higher plants on
earth, less than 10% have been screened for their pharma-
ceutical potential and in many instances only one activity
has been studied (Hamburger and Hostettmann 1991). The
bioactivities and chemical composition of many more
species have never been studied (Rasoanaivo and
Ratsamimanga 1993).
A number of research publications on the constituents and
biological activity of African medicinal plants is available but
the development of therapeutic agents from these plants has
remained rather neglected. This is despite the fact that mod-
ern antimicrobial chemotherapy has much of its origin in
tropical medicine and chemotherapy (Ryley 1995).
Documentation of African medicinal plants has also not been
done as fully as in other societies, such as the Indian and
Chinese societies (Iqbal et al. 1998), though more than 80%
of Africa’s population still use plant extracts to cure many
forms of disease (Iwu 1993). However, industrialisation has
led to a decrease in the number of plants being used as well
as a high probability of losing knowledge of the useful plants
(Verpoorte 1986).
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Of particular importance is the opinion frequently
expressed in literature that infectious diseases no longer
pose a problem as a result of the development of antibiotics
and vaccines, but this is not correct. Although many patho-
genic microorganisms can be controlled with currently avail-
able antibiotics (Zähner and Fiedler 1995), mankind is prob-
ably further away from mastering infectious diseases than it
was 25 years ago (Kubo 1995). This has been attributed to
changes in the spectrum of pathogens, examples being the
AIDS virus, atypical mycobacteria, aspergilli, Cryptococcus
neoformans, Listeria and Legionella. It has been stated that
antibiotic-resistant pathogens are on the increase, particu-
larly in hospitals. In the past, multi-resistant Gram-negative
bacteria were problematic. Today it is the multi-resistant
Gram-positive bacteria that are of concern, especially
Staphylococcus aureus (MRSA-methicillin-resistant S.
aureus), enterococci and pneumococci. The resistance of
these strains can be noted against over ten different antibi-
otics (Zähner and Fiedler 1995). It is worth mentioning that
the development of resistance to antifungal drugs in medi-
cine has been less of a problem than with antibacterial
agents (Hunter 1995), although this does not mean that
there is no need to search for alternative cures of fungal
infections (Russel et al. 1995).
An important factor is the cost of drugs. Validated, non-
toxic medicinal preparations may be cheaper for rural
patients, and more readily available. Further, an increase in
the frequency of bacterial diseases and the fact that com-
pounds of plant origin are often more effective than their
synthetic analogues (Van den Berghe et al. 1978, Van den
Berghe and Vlietinck 1991, Elisabetsky and Posey 1994)
necessitates the development of plant derived antibacterial
agents as safer and more effective alternatives. E. crispa
subsp. crispa is known as one of the most common trees in
South Africa (Venter 1976, Malan et al. 1998). Although
Euclea species are extensively utilised in traditional medi-
cine for a wide range of ailments, including gonorrhea,
wounds, leprosy, scabies and dysentery (Khan and Rwekika
1992), E. crispa subsp. crispa is the least documented of the
subspecies in terms of its application potential. An infusion
of the root bark is used as a cough remedy as well as for the
treatment of measles and melanomas (Sibanda et al. 1992)
but the active substances responsible for curing each of
these diseases are not known. No mention has been made
in the literature of uses for the leaves.
Phytochemical analysis of E. crispa and a few other
species belonging to the family Ebenaceae has been
attempted (Costa et al. 1976, Khan and Rwekika 1992,
Sibanda et al. 1992). Pentacyclic triterpenoids lupeol, betulin
and oleanolic acid were isolated from the root bark of E.
crispa (Sibanda et al. 1992) while Hutchings et al. (1996)
reported that roots of Euclea species as well as leaves of
other species from the family Ebenaceae have been found
to be rich in naphthaquinones. Dark coloured naph-
thaquinones, or their derivatives, are commonly produced in
leaves of Euclea species and 27 naphthaquinone deriva-
tives have been isolated from plants belonging to the family
Ebenaceae (Hutchings et al. 1996). Other compounds iso-
lated from species of this family include phytosterols and ter-
penoids (Sibanda et al. 1992). However, whether any of
these secondary metabolites possess antibacterial proper-
ties remains to be shown.
Antibacterial properties of a crude as well as a semi-puri-
fied ethyl acetate fraction prepared from dried and ground
Euclea crispa subsp. crispa leaves were previously reported
(Magama et al. 2003, Pretorius et al. 2003). This paper
reports on the isolation of compounds responsible for activi-
ty.
Materials and Methods
Plant material
Plant leaf material was collected in the Bloemfontein area of
the Free State Province, South Africa, during the summer of
March 1998. The plant was identified and authenticated by
taxonomists from the National Museum Bloemfontein and a
voucher specimen deposited in the museum’s herbarium
under the number NMB20 483. Plant material was dried at
45°C for two weeks in an aerated oven and grounded using
a Retsch SM2000 cutting mill before a crude extract was
prepared as explained previously (Magama et al. 2003).
Other materials and chemicals
Silica gel 60 F254-aluminium backed and pre-coated 20cm x
20cm plates, with the silica spread to 0.1mm thickness and
treated with a luminescent agent (254nm), were purchased
from Merck (Germany) and used for analytical thin layer
chromatography (TLC). Silica gel F1500/LS glass backed
preparative thin layer chromatography (P-TLC) plates, pre-
coated to 0.5mm thickness, as well as all solvents used
were from Merck (Germany). Analytical and preparative TLC
as well as liquid–liquid extraction was performed with sol-
vents of the highest purity available (analytical grade).
Flavonoid standards were obtained from Sigma.
Preparation of a crude leaf extract and semi-purified
fractions
A crude leaf extract and semi-purified fractions were
obtained as described previously (Magama et al. 2003).
Further purification was continued with the ethyl acetate
fraction obtained after liquid–liquid extraction of the crude
extract.
Antibacterial tests
A disk diffusion method (Rios et al. 1988) was used to
screen for antibacterial activity in crude and semi-purified
extracts at concentrations of 1mg ml–1 and 50µg ml–1 respec-
tively. To obtain the desired test concentrations, the dried
crude extract, chloroform- and ethyl acetate fractions were
dissolved in a 10% (v/v) solution of DMSO in water. The less
polar hexane and diethyl ether extractives were dissolved in
a 10% (v/v) solution of Tween-80 in water. All experiments
were repeated twice and every extract was tested in tripli-
cate. At the end of the 48h incubation period, inhibition
zones were measured with a transparent ruler on two axes
at right angles to each other to give two readings from each
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test. The measurement included the diameter of the disc
which was 6mm (March et al. 1991, Pfaller et al. 1992).
Eleven clinical isolates of human pathogenic bacteria
were used to test for antibacterial activity in the crude
extract, semi-purified fractions and compounds purified from
the ethyl acetate fraction. These were Acinetobacter bau-
manii, Bacillus subtilis, Escherichia coli, Haemophilus
influenza, Klebsiella pneumoniae, Moraxella catarrhalis,
Pseudomonas aeruginosa, Staphylococcus aureus,
Staphylococcus epidermidis, Streptococcus pneumoniae
and Streptococcus pyogenes. To initially identify those com-
pounds purified from the ethyl acetate fraction as the
antibacterially active compounds, Moraxella catarrhalis (pre-
viously known as Branhamella catarrhalis; Jones and Barry
1990) was used as test organism as it proved to be the most
sensitive of all bacteria tested. In all screening procedures
both negative (solvent blanks) and positive (antibiotics) con-
trols were used.
Preliminary phytochemical screening of compounds in
the active ethyl acetate fraction
Compounds in the active semi-purified ethyl acetate fraction
were separated on silica gel 60 F254-aluminium backed and
pre-coated (0.1mm) plates, cut to 10cm x 3cm, by using dif-
ferent solvent systems for different chemical groups as
described by Wagner and Bladt (1996). Ethyl
acetate:methanol:water (100:13.5:10) was used as mobile
phase in all cases except for the test for essential oils where
toluene:ethyl acetate (93:7) was used as mobile phase.
Tests for different chemical groups, including alkaloids,
anthraglycosides, bitter principles, cardiac glycosides,
coumarins, essential oils, flavonoids, phenolic compounds,
saponins and valepotriates, were performed on separate
TLC plates using specific staining reagents according to the
standard methods described by Wagner and Bladt (1996).
Control plates were also sprayed with 5% ethanolic H2SO4 in
order to detect all possible carbon containing compounds in
the fraction (Wagner and Bladt 1996).
Purification of antibacterial compounds from the active
ethyl acetate fraction by means of preparative thin layer
chromatography (P-TLC)
Preparative thin layer chromatography (P-TLC) was per-
formed on 20cm x 20cm silica gel F1500/LS (0.5mm) plates.
Fifteen mg of the ethyl acetate fraction were dissolved in 50µl
of an ethyl acetate:methanol:water (100:13.5:10) solvent sys-
tem and loaded onto the plate by streaking evenly over the
baseline with the aid of a glass capillary tube. This was
repeated 10 times on 10 different plates to separate com-
pounds from a total of 150mg of the ethyl acetate fraction.
The plates were dried in front of a fan and then developed in
a saturated chamber (Mikes and Chalmers 1979) in the same
solvent system in which the residue was dissolved.
Detection of compounds was done under UV-light at 254
and 365nm. Individual compounds were isolated by scraping
off the detected zones of the sorbent layer from the plates
using a spatula and transferred into a micro column packed
with cotton wool. The compounds were recovered from the
silica by elution with acetone and tested for antibacterial
activity. Only the active isolated compounds were again test-
ed for purity in an original analytical TLC system (Mikes and
Chalmers 1979) using Silica gel 60 F254-aluminium backed
and pre-coated plates with ethyl acetate:formic acid:glacial
acetic acid:water (100:11:11:26) (Wagner and Bladt 1996)
as mobile phase. The acetone was evaporated under
reduced pressure at 35°C in a rotary evaporator. The pure
compounds were further dried in a vacuum oven in prepara-
tion for structure elucidation by comparison with standards in
a TLC system, gas chromatographic–mass spectroscopy
(GC-MS) or by proton nuclear magnetic resonance spec-
troscopy (1HNMR).
Identification of purified active compounds
TLC comparison with standards
The phytochemical groups to which the purified compounds
belonged were initially identified by applying standard stain-
ing procedures (Wagner and Bladt 1996). Two of the six
active compounds were subsequently identified by means of
TLC comparing with commercially available standards.
Gaschromatographic-mass spectroscopy (GC-MS)
One of the active compounds was identified by means of a
Hewlett Packard GC6890–MS5973 gas chromatographic–
mass spectrometer, following the instructions of the suppliers.
Nuclear magnetic resonance spectroscopy (NMR)
Three of the active compounds that could not be identified
by other means, were identified by NMR spectroscopy.
1HNMR was performed using a Bruker 300MHz DRX 300
spectrometer at 296K (23°C). The solvents used were deu-
terio chloroform (CDCL3) or deuterio acetone [(CD3)2CO].
Dissolved samples were placed in glass tubes (5mm outer
diameter) of varying lengths and up to 15cm long. Only
3–5cm of the length of the tube was filled with 0.4–0.7ml sol-
vent. The tube containing sample was sealed with a plastic
cap and mounted in a turbine assembly before being placed
in the spectrometer. The tube was spun at high speed
(300Hz) about its vertical axis, which smoothed inhomo-
geneities in the magnetic field. Chemical shifts were report-
ed in parts per million (ppm) on the δ-scale against tetram-
ethylsilane (TMS) = 0.0ppm (Harwood and Moody 1989).
The coupling constants were given in Hz. The relative num-
ber of protons contributing to the absorption was given to the
nearest integer, together with any multiplicity of the absorp-
tion and related coupling constants. The following abbrevia-
tions were used: s – singlet; d – doublet; dd – doublet of dou-
blets; m – multiplet; J – coupling constant.
Results
Preliminary phytochemical screening of the compounds in
the ethyl acetate fraction of the crude E. crispa subsp. crispa
extract qualitatively separated on a control TLC plate and
sprayed with 5% ethanolic H2SO4, revealed the presence of
fifteen compounds or groups of multiple compounds with Rf-
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values ranging from 0.04 to 0.99 (Table 1). Treatment of
these compounds separated on different TLC plates with dif-
ferent staining reagents (Wagner and Bladt 1996) in order to
identify phytochemical groups, showed the presence of bit-
ter principles (Rf = 0.99; 0.61; 0.58; 0.54; 0.50; 0.45; 0.36),
alkaloids (Rf = 0.77; 0.61; 0.50), phenolic compounds (Rf =
0.92; 0.82; 0.77; 0.72; 0.58; 0.54; 0.50; 0.45; 0.36), saponins
(Rf = 0.90; 0.58; 0.50; 0.45; 0.29; 0.10) and essential oils (Rf
= 0.04) (Table 1). The ethyl acetate fraction tested negative
for anthraglycosides, cardiac glycosides, valepotriates and
coumarins.
After the compounds or groups of multiple compounds
were separated by means of preparative TLC, eluted and
tested for antibacterial activity against Moraxella catarrhalis,
only six compounds or groups of multiple compounds were
active (Table 1). These had calculated Rf values of 0.92,
0.82, 0.77, 0.72, 0.61 and 0.54 respectively. Only these
active compounds or groups of multiple compounds were
purified further by means of P-TLC and tested for purity
using analytical TLC (Mikes and Chalmers 1979).
As five of the six active compounds tested positive for
phenols, and flavonoids are the most abundant naturally
occurring phenolic compounds, TLC comparisons of the
active ethyl acetate fraction with nine commercially available
flavonoid standards were prepared. In this way two
flavonoids, testing positive for antibacterial activity, were
identified as hyperoside (Rf = 0.58) and quercitrin (Rf = 0.72)
(Table 2, Figure 1).
The name and structure of the active compound with a Rf-
value of 0.61 could not be confirmed but was identified as a
terpenoid with a cholesterol-like structure by means of
GC–MS (Table 3). This compound tested positive for bitter
principles and saponins with the appropriate spray reagents
(Wagner and Bladt 1996). It possessed significant antibac-
terial activity towards M. catarrhalis.
The remaining three purified active compounds were all
flavonoids and identified as epicatechin (Rf = 0.92), catechin
(Rf = 0.82) and gallocatechin (Rf = 0.77) (Table 3, Figure 1)
by means of NMR spectroscopy. The 1HNMR spectrum
(CDCl3) of epicatechin (Figure 1) was H-2’, δ 7.49, d,J =
2.5Hz; H-6’, δ 7.33, dd,J = 8.5Hz; H-5’, δ 7.08, d,J = 8.5Hz
for the B-ring, H-6, δ 6.49, d,J = 2.5Hz; H-8, δ 6.21, d,J =
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Table 1: Rf values, distribution of phytochemical classes and antibacterial activity of compounds in an ethyl acetate fraction of an Euclea
crispa subsp. crispa extract after further separation of compounds by means of preparative and qualitative TLC
Rf values of spots on TLC plates Phytochemical class Antibacterial activity against Moraxella catarrhalis
0.99 Bitter principle 0 ± 0
0.92 Phenolic 14.0 ± 0.4
0.90 Saponin 0 ± 0
0.82 Phenolic 12.0 ± 0.6
0.77 Phenolic, alkaloid 11.0 ± 0.8
0.72 Phenolic 10.0 ± 0.7
0.61 Bitter principle, alkaloid 15.0 ± 0.4
0.58 Phenolic, saponin 11.0 ± 0.4
0.54 Bitter principle; Phenolic 0 ± 0
0.50 Bitter principle; Saponin; Alkaloid, Phenolic 0 ± 0
0.45 Bitter principle; Saponin; Phenolic 0 ± 0
0.36 Bitter principle; Phenolic 0 ± 0
0.29 Saponin 0 ± 0
0.10 Saponin 0 ± 0
0.04 Essential oil 0 ± 0
Table 2: Identification of flavonoids with antibacterial activity in an ethyl acetate fraction of Euclea crispa subsp. crispa leaves using com-
mercially available standards in a TLC system (ethyl acetate:formic acid:glacial acetic acid:water = 100:11:11:26)
Reference compound Rf-value of Rf-value of compounds Positively Antibacterial
reference compound purified from an ethyl identified flavonoids activity
acetate fraction
Kaempferol 0.98 0.99 –
Quercitin 0.96 –
Dihidroquercitin 0.95 –
0.92 – Active
Hypericin 0.82 0.82 – Active
0.77 – Active
Quercitrin 0.72 0.72 Quercitrin Active
0.61 – Active
Hyperoside 0.58 0.58 Hyperoside Active
Chlorogenic Acid 0.50 0.50 –
Rutoside 0.44 0.45 –
Rutin 0.04 0.04 –
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2.5Hz for the A-ring and H-2, δ 5.41, d,J = 2.5Hz; Hm-3, δ
4.22, d,J = 8.5; H-4, δ 3.37, m,J = 12.0Hz for the C-ring.
In the case of catechin (Figure 1) the 1HNMR spectrum
(CDCl3) displayed an aromatic ABX system for the B-ring.
(H-2, δ 6.89, d,J = 2.5Hz; H-5’, δ 6.79, d,J = 10.5Hz; H-5’, δ
6.73, dd, J = 8.5Hz; H-6’, δ 6.73, dd,J = 9.5Hz). The spec-
trum for the A-ring was H-6, δ 6.02, d,J = 2.5Hz; H-8, δ 5.85,
d,J = 2.5Hz and H-2, δ 4.51, d,J = 8.0Hz; H-3, δ 3.69, m,J =
25Hz; Heq -4, δ 2.89, dd,J = 16.0Hz; Hax-4, δ 2.495, dd,J =
16.0Hz for the C-ring.
An ABX system for the B-ring was displayed for gallocate-
chin (Figure 1), just like for the other two flavan-3-ols. The B-
ring also displayed two proton singlets at positions H-2’ and
H-6’, δ 6.45 while the spectrum for the A-ring was H-6, δ
6.01, d,J = 4.0Hz; H-8, δ 5.89, d,J = 4.0Hz. C-ring (H-2, δ
4.47, d,J = 8.0Hz; H-3, d 3.98, d,J = 25.0Hz; Heq-4, δ 2.85,
dd,J = 16Hz; Hax-4, δ 2.85, dd,J = 16Hz).
In vitro growth inhibition of B. subtilis was only obtained
with epicatechin and hyperoside, while the latter also had an
inhibiting effect on the growth of H. influenzae (Table 4). All
five flavonoids, as well as the purified terpenoid, inhibited
the growth of M. catarrhalis while K. pneumoniae was only






	


 


















 !	













Figure 1: Five flavonoids with antibacterial properties purified from Euclea crispa subsp. crispa leaves.
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inhibited by epicatechin (Table 4). Except for M. catarrhalis,
the terpenoid had no inhibiting effect on any of the other
human pathogenic bacteria. Most of the activity was against
M. catarrhalis. Epicatechin and hyperoside were the most
active, in terms of a broader spectrum of control, inhibiting
three bacterial species each. The lowest activity was
observed for catechin, gallo-catechin and quercitrin; each
only inhibiting the growth of M. catarrhalis. No antibacterial
activity was observed with any of the six purified compounds
towards E. coli, S. aureus, S. epidermidis, P. aeruginosa, S.
pyogenes and A. baumanii at a concentration of 1mg ml–1.
Discussion
Euclea species are widely used as a traditional medicine in
some African countries for the treatment of some infectious
diseases (Khan and Rwekika 1992, Sibanda et al. 1992).
Khan and Rwekika (1992) also reported the isolation of
triterpenoids from the leaves of E. natalensis. A number of
terpenoids are known to possess antimicrobial activity (Kubo
et al. 1992, Chen et al. 1993, Li et al. 1993). The terpenoid
isolated from the leaves of E. crispa subsp. crispa in this
study, due to its steroid-like structure, might be one of the
triterpenoids characteristic of Euclea species. Of the isolat-
ed flavonoids, epicatechin was the most potent as evi-
denced by the broader spectrum of antibacterial activity and
larger inhibition zones in the disc diffusion assay (Rios et al.
1988). This technique is widely used for antibiotic suscepti-
bility testing as well as for screening possible medicinal
plants (Kavanagh 1975, Gordon et al. 1980, El-Abyad et al.
1990, Irobi and Daramola 1993).
However, in general, the antibacterial activity of the puri-
fied terpenoid as well as that of the five flavonoids was lower
in comparison to that of the intact ethyl acetate fraction from
which the compounds were isolated. This occurrence could
have been due to the possibility that these compounds func-
tion in synergy, either together with each other or with a
range of other compounds. It is well known that medicinal
plant extracts are used either as complex mixtures or as
pure compounds depending on their therapeutic indices.
Considering that the ethyl acetate leaf fraction was the most
active, it would appear hat antibacterial compounds from E.
crispa subsp. crispa are more effective as complex mixtures
in the form of crudely fractionated extracts.
The activity of the crude methanol extract was in some
cases higher than that of the ethyl acetate fraction, espe-
cially against human pathogenic fungi (Magama et al. 2003).
This supports the suggestion that the more complex extracts
of E. crispa subsp. crispa are more potent than the pure
compounds due to a possible synergistic effect. This does
not mean that there is no need to isolate and study the con-
stituents of plant extracts separately. Reasons for investigat-
ing individual constituents of an extract include the determi-
nation of toxicity and most useful dosage.
Flavonoids are known for their antioxidant (Watanabe
1998, Heinonen et al. 1998, Gardner et al. 1998, Meyer et
al. 1998) and anti-inflammatory activity (Ibewuike et al.
1997). However, some flavonoids possess antimicrobial
activity as well (Markham 1989, Van der Watt and Pretorius
2001). The ethyl acetate fraction of a methanol extract from
Calliandra haematocephala (Mimosaceae) was found to be
active against Staphylococcus aureus and Bacillus subtilis
(Nia et al. 1999). From this ethyl acetate fraction, the authors
reported the isolation of the following flavonoids: p-hydroxy-
benzoic acid, caffeic acid, protocatechuic acid, catechin-3-
rhamnoside and epicatechin-3-rhamnoside as well as
Table 3: Identification of antibacterial compounds by means of GC–MS or NMR spectroscopy
Rf-values of compounds purified Method of identification Positively identified compounds Antibacterial activity
from an ethyl acetate fraction
0.92 NMR spectroscopy Epicatechin (Flavonoid) Active
0.82 NMR spectroscopy Catechin (Flavonoid) Active
0.77 NMR spectroscopy Gallocatechin (Flavonoid) Active
0.61 GC–MS Cholesterol-like structure (Terpenoid) Active
Table 4: Antibacterial activity of compounds purified from an ethyl acetate fraction of Euclea crispa subsp. crispa leaves against human path-
ogenic bacteria at 50µg disk–1
Bacteria Mean inhibition zone diameter (mm)
Gram (+) or (–) Epicatechin Catechin Gallocatechin Quercitrin Terpenoid Hyperoside Standard antibiotic
A. baumanii (–) 0 0 0 0 0 0 17.0 ± 0.0 a
B. subtilis (+) 12.0 ± 0.4 0 0 0 0 8.0 ± 0.4 35.0 ± 0.4 b
E. coli (–) 0 0 0 0 0 0 18.0 ± 0.4 b
H. influenzae (–) 0 0 0 0 0 8.0 ± 0.6 29.0 ± 0.4 b
K. pneumoniae (–) 12.0 ± 0.40 0 0 0 0 0 33.0 ± 0.6 b
M. catarrhalis (–) 14.0 ± 0.4 12.0 ± 0.6 11.0 ± 0.8 10.0 ± 0.7 15.0 ± 0.4 11.0 ± 0.4 18.0 ± 0.6 a
P. aeruginosa (–) 0 0 0 0 0 0 32.0 ± 0.0 b
S. aureus (+) 0 0 0 0 0 0 32.0 ± 0.4 b
S. epidermidis (+) 0 0 0 0 0 0 33.0 ± 0.0 b
S. pneumoniae (+) 12.0 ± 0.3 0 0 0 0 0 21.0 ± 0.6 b
S. pyogenes (+) 0 0 0 0 0 0 28.0 ± 0.4 c
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quercetin. However, the activity of individual constituents
was not shown.
The flavonol glycosides kaempferol-3-O-glucoside (astra-
galin), quercetin-3-O-galactoside (hyperoside), quercetin 3-
O-rutinoside (rutin) together with kaempferol-3-O-rutinoside
(nicotiflorin) are known to be the main flavonol glycosides of
Eupatorium guayanum (Compositae) widely used in Peru for
the treatment of colds, among other illnesses (Aquino et al.
1995). Hyperoside and rutin isolated from the methanol
extract of Arcytophyllum nitidum (Rubiaceae) have been
shown to be effective against a number of Gram negative
bacteria, including E. coli, with the antibacterial action of
these flavonoids attributed to their action on cell membrane
permeability (Aquino et al. 1995).
Catechins have been found to possess potentially valu-
able properties as they inhibit the growth of both Gram-neg-
ative and Gram-positive bacteria by damaging the lipid bilay-
er (Isogai et al. 1998). Catechins are also effective in the
inhibition of canine periodontal disease in vivo (Isogai et al.
1998). Fukunaga et al. (1989) observed that quercitrin has
antibacterial activity towards Staphylococcus aureus,
Escherichia coli, Pseudomonas aeruginosa and Klebsiella
pneumoniae, with MIC’s greater than 400µg cm–3 for the first
three bacterial species and only 400µg cm–3 for K. pneumo-
niae. However, activity towards S. aureus, E. coli and P.
aeruginosa was not observed in this study, probably due to
lower dosages applied. Quercitrin and catechin have been
shown to also be effective against the herpes simplex virus
type 1 (HSV-1), parainfluenza virus type 3 (Pf-3) and Sindbis
virus (SV-1) (Aquino et al. 1995).
In addition to the above mentioned properties of
flavonoids as biologically active compounds, they possess
the following characteristics that make them ideal
chemotherapeutic agents. Flavonoids are (a) wide spread,
(b) their patterns seem to be species specific, (c) are easy to
detect, chromatograph and identify, (d) they are relatively
stable and (e) their biosynthesis and accumulation is inde-
pendent of environmental influence (Markham 1989). The
fact that one of the functions of flavonoids in plants is to pro-
tect them against diseases caused by micro-organisms
means that they have the potential to be used in crop pro-
tection as well. The inhibition of plant pathogenic bacteria
and fungi by the ethyl acetate fraction of E. crispa leaves has
been reported previously (Pretorius et al. 2003). A potential
drawback is that, since flavonoids are phenolic compounds,
they react with proteins and can thus interact with enzymes
and biological processes in cells, consequently making them
toxic to some micro-organisms and animals (Grayer 1989,
Markham 1989).
This is the first report of catechin, epicatechin, gallocate-
chin, hyperoside and quercitrin from E. crispa subsp. crispa
leaves. If further investigation of the semi-purified ethyl
acetate fraction reveals no significant toxicity, the applica-
tions of this extract with its synergistic antibacterial com-
pounds, for example in the external disinfection of wounds,
should be considered.
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